What drug-data ruling means for pharma firms and you - health - 03 October 2014 - New Scientist

"Should you have the right to know everything that drug companies know about the medicines you take? Researchers and transparency campaigners have been lobbying the European Medicines Agency (EMA), the body that holds this data, to make it publicly available. They argue that holding back drug information makes it hard for patients and doctors to make informed decisions about treatment, and increases the chance that drug trials will be needlessly repeated, wasting money. Some drug companies are reluctant, citing concerns about commercial privacy. Yesterday, the EMA announced what it plans to do ..."